Indapta Therapeutics logo

Indapta Therapeutics Funding & Investors

Houston, TX

Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.

indapta.com

Total Amount Raised: $77,000,000

Indapta Therapeutics Funding Rounds

  • Series Unknown

    $22,500,000

    Series Unknown Investors

    RA Capital Management
    Vertex Ventures HC
    Myeloma Investment Fund
    Leaps by Bayer
    Pontifax

  • Grant

    $4,500,000

    Grant Investors

    CPRIT

  • Series A

    $50,000,000

    Series A Investors

    Leaps by Bayer
    RA Capital Management
    Vertex Ventures
    Myeloma Investment Fund
    Lonza
Funding info provided by Diffbot.